Results 231 to 240 of about 67,862 (241)

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

Lancet, The, 2010
Michael Friedlander, Clare L Scott, Jeffrey N Weitzel   +2 more
exaly  

CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair

Nature, 2005
Fumiko Esashi, Yilun Liu, Tim Hunt
exaly  

BRCA1 and BRCA2: 1994 and beyond

Nature Reviews Cancer, 2004
Steven A Narod, William D Foulkes
exaly  

Cancer Susceptibility and the Functions of BRCA1 and BRCA2

Cell, 2002
Ashok R Venkitaraman
exaly  

Population-based study of risk of breast cancer in carriers of BRCA2 mutation

Lancet, The, 1998
Steinunn Thorlacius, Jeffery P Struewing, Laufey Tryggvadottir   +2 more
exaly  

A Class of Environmental and Endogenous Toxins Induces BRCA2 Haploinsufficiency and Genome Instability

Cell, 2017
Yansheng Liu, Xavier Renaudin, Ruedi Aebersold   +2 more
exaly  

Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations

Nature Reviews Cancer, 2007
Olufunmilayo I Olopade
exaly  

Role of BRCA2 in Control of the RAD51 Recombination and DNA Repair Protein

Molecular Cell, 2001
Jean-Yves Masson, Andrzej Stasiak, Ashok R Venkitaraman   +2 more
exaly  

A glycolytic metabolite bypasses “two-hit” tumor suppression by BRCA2

Cell
Li Ren Kong, Tuan Zea Tan, Elayanambi Sundaramoorthy   +2 more
exaly  

Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases

Lancet, The, 1997
exaly